Description
Inclusion Criteria:
- * Written informed consent.
- * Both genders, ages 18-60 years
- * Schizophrenia / schizoaffective disorder (DSM V).
- * Treated with the same APD for at least 60 days; Stable dose of APD for \> 1 month, continued throughout the study.
- * PANSS total score of 60 and Score 4 or more on one or more items of the 'positive' syndrome items (P1-P7)
- * Preference for patients with duration of psychosis less than 7 years.
Exclusion Criteria:
- * No illicit substance use in last 30 days/no dependence in 6 months with the exception of methadone treatment for opioid withdrawal.
- * History or current medical /neurological illnesses that may lead to an unstable course with the exception of epilepsy which is well-controlled on an antiepileptic medication for at least 6 months.
- * Pregnancy.
- * History of immune disorders, HIV infection, or receiving immune-suppressants or immuno-modulators, e.g., steroids.
- * Current or prior treatment with CGY or History of hypersensitivity to CGY.
- * Intellectual disability as defined in DSM V.
Ages Eligible for Study:
18 Years to 65 Years (ADULT, OLDER_ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
No